ArticleJoint diseases and related surgery2026
Fibrous dysplasia: Clinical features, deformities, management, and outcomes.
Article in Joint diseases and related surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fibrous dysplasia: clinical and pathologic characteristics, surgical approaches, and outcomes in a large Italian cohort.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2026Article
- Case Report: Total hip arthroplasty via the direct anterior approach using a cementless revision stem without corrective osteotomy for fibrous dysplasia.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of this study was to evaluate the rate of proximal femoral involvement and the incidence of shepherd's crook deformity in patients with fibrous dysplasia (FD) and to identify possible factors associated with the development of shepherd's crook deformity. PATIENTS AND
methodsBetween January 1990 and December 2022, a total of 158 consecutive patients (78 males, 80 females; mean age: 23.8 ± 15.0 years; range, 3 to 71 years) diagnosed with FD were retrospectively analyzed. Presenting symptoms, lesion location, radiological findings, treatment modalities, development of deformity, postoperative complications, and the need for secondary surgery were recorded.
resultsThe mean follow-up was 64.2 ± 38.4 (range, 24 to 210) months. Among the patients, 125 had monostotic and 33 had polyostotic lesions. Of the 215 lesions identified, 83 were treated surgically, while 132 were managed with clinical observation. Shepherd's crook deformity was observed in nine of 75 proximal femoral lesions. The deformity was significantly more common in polyostotic than in monostotic lesions (25.0% vs. 5.9% respectively; p = 0.026). McCune-Albright syndrome (MAS) was present in two patients, both exhibiting shepherd's crook deformity, whereas the rate was 9.6% among patients without MAS. Valgus osteotomy was performed in all nine patients with shepherd's crook deformity, improving the mean neck-shaft angle from 90.5° (range, 85 to 105°) preoperatively to 125.6° (range, 120 to 130°) postoperatively. In six of these patients, no marked loss in the postoperative neck-shaft angle was observed, while three patients required secondary surgery due to recurrence of the deformity.
conclusionMost lesions can be managed successfully with observation, while surgery is indicated for the eradication of symptomatic lesions, prevention of pathological fractures, and correction of deformities. Shepherd's crook deformity seems to be more common in patients with polyostotic lesions and MAS. Although valgus osteotomy can achieve radiographic improvement, recurrence of deformity and the need for multiple surgeries are not uncommon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.